These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23078549)

  • 1. Global impact of antiretroviral therapy-associated diarrhea.
    Gupta R; Ordonez RM; Koenig S
    AIDS Patient Care STDS; 2012 Dec; 26(12):711-3. PubMed ID: 23078549
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphoma in an HIV-positive patient.
    Manciuc C; Dorobăţ C; Dănăilă C; Largu MA
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):97-100. PubMed ID: 25970950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Folliculitis and renewed immunocompetence in HIV-positive subjects after antiretroviral treatment].
    Ann Dermatol Venereol; 2001 Apr; 128(4):579. PubMed ID: 11395664
    [No Abstract]   [Full Text] [Related]  

  • 4. Coinfection with hepatitis viruses and HIV: good and bad news.
    Laurence J
    AIDS Patient Care STDS; 2001 Dec; 15(12):599-602. PubMed ID: 11788072
    [No Abstract]   [Full Text] [Related]  

  • 5. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization.
    Azar MM; Springer SA; Meyer JP; Altice FL
    Drug Alcohol Depend; 2010 Dec; 112(3):178-93. PubMed ID: 20705402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada.
    O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both improvement and worsening of adherence to antiretroviral treatment can be expected while transitioning HIV-positive adolescents to adult health care.
    Kowalska JD; Popielska J; Wroblewska A; Firląg-Burkacka E; Horban A; Marczyńska M
    Infect Dis (Lond); 2019 Jun; 51(6):463-466. PubMed ID: 30856034
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute promyelocytic leukemia in an HIV-infected patient: a case report.
    De Vita S; De Matteis S; Laurenti L; Sorà F; Tarnani M; Cingolani A; Sica S
    Am J Hematol; 2006 Apr; 81(4):300. PubMed ID: 16550512
    [No Abstract]   [Full Text] [Related]  

  • 9. Focal epithelial hyperplasia (Heck disease) related to highly active antiretroviral therapy in an HIV-seropositive child. A report of a case, and a review of the literature.
    Feller L; Khammissa RA; Wood NH; Malema V; Meyerov R; Lemmer J
    SADJ; 2010 May; 65(4):172-5. PubMed ID: 20632701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of noninfectious diarrhea associated with HIV and highly active antiretroviral therapy.
    Macarthur RD
    Am J Manag Care; 2013 Sep; 19(12 Suppl):s238-45. PubMed ID: 24495294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antiretroviral therapy and associated factors among Human immunodeficiency virus positive patients accessing treatment at Nekemte referral hospital, west Ethiopia, 2019.
    Abadiga M; Hasen T; Mosisa G; Abdisa E
    PLoS One; 2020; 15(5):e0232703. PubMed ID: 32392244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulomatous cheilitis in an HIV positive patient on HAART therapy.
    Dalessandro M; Vecchiet J; Angelucci D; Pizzigallo E; Tulli A; Amerio P
    Eur J Dermatol; 2008; 18(5):591. PubMed ID: 18779107
    [No Abstract]   [Full Text] [Related]  

  • 13. Highly active antiretroviral therapy-associated flare of oropharyngeal Kaposi sarcoma.
    Naidu TK; Ramdial PK; Naidoo SK
    Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):762-4. PubMed ID: 22911300
    [No Abstract]   [Full Text] [Related]  

  • 14. Low prevalence of cardiac abnormalities in an HIV-seropositive population on antiretroviral combination therapy.
    Bijl M; Dieleman JP; Simoons M; van der Ende ME
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):318-20. PubMed ID: 11464156
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis.
    Werb D; Mills EJ; Montaner JS; Wood E
    Lancet Infect Dis; 2010 Jul; 10(7):464-9. PubMed ID: 20610328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral blindness after starting highly active antiretroviral treatment in a patient with HIV infection and cryptococcal meningitis.
    De Schacht C; Smets RM; Callens S; Colebunders R
    Acta Clin Belg; 2005; 60(1):10-2. PubMed ID: 15981698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BCGitis due to immune reconstitution in an HIV positive child].
    Gamero DB; García BS; Conejo PR; Gónzalez-Granado LI
    An Pediatr (Barc); 2012 Feb; 76(2):107. PubMed ID: 21778124
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in prevention: improving cardiovascular risk management among human immunodeficiency virus-positive individuals.
    Farley JE; Tudor C; Dennison CR
    J Cardiovasc Nurs; 2010; 25(4):259-60. PubMed ID: 20539159
    [No Abstract]   [Full Text] [Related]  

  • 19. Surreptitious antiretroviral use as an explanation for apparent elite HIV control.
    Costiniuk CT; La Porte CJ; Angel JB
    AIDS Patient Care STDS; 2012 Nov; 26(11):645-6. PubMed ID: 23003207
    [No Abstract]   [Full Text] [Related]  

  • 20. Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era.
    MacArthur RD; DuPont HL
    Clin Infect Dis; 2012 Sep; 55(6):860-7. PubMed ID: 22700829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.